Neurotrophic Keratitis

SAN DIEGO — Patients with stage 1 neurotrophic keratitis experienced significant improvements in corneal sensitivity and best-corrected visual acuity after an 8-week course of Oxervate, according to a study presented at Academy 2022.

The FDA granted orphan drug designation to BRM424 for the treatment of neurotrophic keratitis, according to a press release from Brim Biotechnology.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

CHICAGO – Patients with neurotrophic keratitis are challenging to manage, but clinicians are seeing success with autologous serum, Clark Chang, OD, of Wills Eye Hospital, said at Optometry’s Meeting.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Preeya K. Gupta, MD, FACS, discusses the simplest ways to effectively diagnose and treat patients with neurotrophic keratitis.

NEW YORK – Neurotrophic keratitis is an underdiagnosed and underrecognized problem, Cecelia Koetting, OD, FAAO, said here at Vision Expo East.

If you have made it through the Level 101 introduction course on dry eye disease diagnosis, Level 201 on the basics of treating DED and Level 301 on using advanced therapies for patients who require them, you are ready for a master class.

WAILEA, Hawaii — In this video from Hawaiian Eye, Marjan Farid, MD, discusses different corneal indications for when to use amniotic membrane tissue in the office.